These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2722599)

  • 1. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.
    Kutcher GJ; Burman C
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1623-30. PubMed ID: 2722599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.
    Kutcher GJ; Burman C; Brewster L; Goitein M; Mohan R
    Int J Radiat Oncol Biol Phys; 1991 May; 21(1):137-46. PubMed ID: 2032884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm.
    Lyman JT; Wolbarst AB
    Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):433-6. PubMed ID: 2753766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response-probability volume histograms and iso-probability of response charts in treatment plan evaluation.
    Mavroidis P; Ferreira BC; Lopes Mdo C
    Med Phys; 2011 May; 38(5):2382-97. PubMed ID: 21776773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calculation of normal tissue complication probability and dose-volume histogram reduction schemes for tissues with a critical element architecture.
    Niemierko A; Goitein M
    Radiother Oncol; 1991 Mar; 20(3):166-76. PubMed ID: 1852908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complication probability as assessed from dose-volume histograms.
    Lyman JT
    Radiat Res Suppl; 1985; 8():S13-9. PubMed ID: 3867079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment plan evaluation using dose-volume histogram (DVH) and spatial dose-volume histogram (zDVH).
    Cheng CW; Das IJ
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1143-50. PubMed ID: 10192366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
    Alexander MA; Brooks WA; Blake SW
    Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random sampling for evaluating treatment plans.
    Niemierko A; Goitein M
    Med Phys; 1990; 17(5):753-62. PubMed ID: 2233561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis.
    Martel MK; Ten Haken RK; Hazuka MB; Turrisi AT; Fraass BA; Lichter AS
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):575-81. PubMed ID: 8113100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple method to calculate the influence of dose inhomogeneity and fractionation in normal tissue complication probability evaluation.
    Begnozzi L; Gentile FP; Di Nallo AM; Chiatti L; Zicari C; Consorti R; Benassi M
    Strahlenther Onkol; 1994 Oct; 170(10):590-4. PubMed ID: 7974170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional heart dose reconstruction to estimate normal tissue complication probability after breast irradiation using portal dosimetry.
    Louwe RJ; Wendling M; van Herk MB; Mijnheer BJ
    Med Phys; 2007 Apr; 34(4):1354-63. PubMed ID: 17500466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
    Oetzel D; Schraube P; Hensley F; Sroka-Pérez G; Menke M; Flentje M
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):455-60. PubMed ID: 7673033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms.
    Lyman JT; Wolbarst AB
    Int J Radiat Oncol Biol Phys; 1987 Jan; 13(1):103-9. PubMed ID: 3804804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of patient positioning on dose-volume histogram and normal tissue complication probability for small bowel and bladder in patients receiving pelvic irradiation: a prospective study using a 3D planning system and a radiobiological model.
    Koelbl O; Richter S; Flentje M
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1193-8. PubMed ID: 10613312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of 3-D dose volume analysis to predict radiation hepatitis.
    Lawrence TS; Ten Haken RK; Kessler ML; Robertson JM; Lyman JT; Lavigne ML; Brown MB; DuRoss DJ; Andrews JC; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1992; 23(4):781-8. PubMed ID: 1618671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-volume histograms.
    Drzymala RE; Mohan R; Brewster L; Chu J; Goitein M; Harms W; Urie M
    Int J Radiat Oncol Biol Phys; 1991 May; 21(1):71-8. PubMed ID: 2032898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.